HUP0202741A3 - Pharmaceutical composition available for the therapeutic management of endometriosis and fallopian tube obstruction and process for its preparation - Google Patents
Pharmaceutical composition available for the therapeutic management of endometriosis and fallopian tube obstruction and process for its preparationInfo
- Publication number
- HUP0202741A3 HUP0202741A3 HU0202741A HUP0202741A HUP0202741A3 HU P0202741 A3 HUP0202741 A3 HU P0202741A3 HU 0202741 A HU0202741 A HU 0202741A HU P0202741 A HUP0202741 A HU P0202741A HU P0202741 A3 HUP0202741 A3 HU P0202741A3
- Authority
- HU
- Hungary
- Prior art keywords
- endometriosis
- preparation
- pharmaceutical composition
- fallopian tube
- composition available
- Prior art date
Links
- 201000009273 Endometriosis Diseases 0.000 title 1
- 206010065789 Fallopian tube obstruction Diseases 0.000 title 1
- 208000030843 hydrosalpinx Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15547899P | 1999-09-23 | 1999-09-23 | |
| PCT/EP2000/009212 WO2001021194A2 (en) | 1999-09-23 | 2000-09-20 | Method for the therapeutic management of endometriosis and fallopian tube obstruction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0202741A2 HUP0202741A2 (hu) | 2003-01-28 |
| HUP0202741A3 true HUP0202741A3 (en) | 2003-12-29 |
Family
ID=22555601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0202741A HUP0202741A3 (en) | 1999-09-23 | 2000-09-20 | Pharmaceutical composition available for the therapeutic management of endometriosis and fallopian tube obstruction and process for its preparation |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1214086A2 (hu) |
| JP (2) | JP2003509467A (hu) |
| KR (1) | KR100772852B1 (hu) |
| CN (2) | CN1376070A (hu) |
| AU (1) | AU769482B2 (hu) |
| BG (1) | BG66128B1 (hu) |
| BR (1) | BR0014198A (hu) |
| CA (1) | CA2383510A1 (hu) |
| HK (1) | HK1049117A1 (hu) |
| HU (1) | HUP0202741A3 (hu) |
| IL (1) | IL148185A0 (hu) |
| MX (1) | MXPA02002436A (hu) |
| NO (1) | NO331198B1 (hu) |
| NZ (1) | NZ534836A (hu) |
| PL (1) | PL201898B1 (hu) |
| RU (1) | RU2255759C2 (hu) |
| SK (1) | SK3752002A3 (hu) |
| TR (1) | TR200200738T2 (hu) |
| TW (1) | TWI267373B (hu) |
| UA (1) | UA73956C2 (hu) |
| WO (1) | WO2001021194A2 (hu) |
| ZA (1) | ZA200201374B (hu) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10157628A1 (de) * | 2001-11-26 | 2003-06-12 | Zentaris Ag | Injektionslösung eines LHRH-Antagonisten |
| US7214662B2 (en) | 2001-11-27 | 2007-05-08 | Zentaris Gmbh | Injectable solution of an LHRH antagonist |
| DK2252627T3 (en) | 2008-01-24 | 2017-08-14 | Esperance Pharmaceuticals | MERGER CONSTRUCTION WITH LYTIC DOMAIN AND METHOD FOR PRODUCING AND USING SAME. |
| US20120053122A1 (en) * | 2009-01-22 | 2012-03-01 | Maatschap Interne Geneeskunde Rijnstate | Method for the prophylaxis or treatment of flushing |
| US9492563B2 (en) | 2012-10-30 | 2016-11-15 | Esperance Pharmaceuticals, Inc. | Antibody/drug conjugates and methods of use |
| EP3384930A1 (en) | 2013-03-15 | 2018-10-10 | AbbVie Inc. | Compositions for use in treating heavy menstrual bleeding |
| US12083227B2 (en) | 2017-08-18 | 2024-09-10 | Abbvie Inc. | Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis |
| EA202090461A1 (ru) | 2017-08-18 | 2020-06-29 | Эббви Инк. | Фармацевтические препараты для лечения эндометриоза, миомы матки, синдрома поликистоза яичников или аденомиоза |
| CN112261942A (zh) | 2018-04-19 | 2021-01-22 | 艾伯维公司 | 治疗重度月经出血的方法 |
| EP3560555A1 (en) * | 2018-04-26 | 2019-10-30 | LifeArc | A composition for treating one or more estrogen related diseases |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5064939A (en) * | 1990-02-06 | 1991-11-12 | The Salk Institute For Biological Studies | Cyclic gnrh antagonists |
| SE9301606D0 (sv) * | 1993-05-07 | 1993-05-07 | Per-Christer Oden | Composition for the treatment of impaired hair growth |
| US5658884A (en) * | 1994-07-22 | 1997-08-19 | The Medical College Of Hampton Roads | Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
| MX9700574A (es) * | 1994-07-22 | 1997-12-31 | Hampton Roads Medical College | Metodo para establecer la secrecion de estrogeno tonico ovarico para regimenes terapeuticos prolongados. |
| DE19513662A1 (de) * | 1995-04-08 | 1996-10-10 | Schering Ag | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
| DE19604231A1 (de) * | 1996-01-29 | 1997-07-31 | Schering Ag | Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen |
| RU2108583C1 (ru) * | 1996-07-29 | 1998-04-10 | Николай Владимирович Рымашевский | Способ определения показаний к проведению гормонотерапии у больных генитальным эндометриозом |
| CN1228708A (zh) * | 1996-09-04 | 1999-09-15 | 有限会社多特 | 经口给药用含肽药物组合物 |
| JP2002502426A (ja) * | 1997-06-05 | 2002-01-22 | メルク エンド カンパニー インコーポレーテッド | ゴナドトロピン放出ホルモンの拮抗薬 |
| DE19911771B4 (de) * | 1999-03-17 | 2006-03-30 | Zentaris Gmbh | LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung |
-
2000
- 2000-09-20 HK HK03101215.4A patent/HK1049117A1/zh unknown
- 2000-09-20 MX MXPA02002436A patent/MXPA02002436A/es active IP Right Grant
- 2000-09-20 PL PL353244A patent/PL201898B1/pl not_active IP Right Cessation
- 2000-09-20 NZ NZ534836A patent/NZ534836A/en not_active IP Right Cessation
- 2000-09-20 RU RU2002111000/14A patent/RU2255759C2/ru not_active IP Right Cessation
- 2000-09-20 TR TR2002/00738T patent/TR200200738T2/xx unknown
- 2000-09-20 HU HU0202741A patent/HUP0202741A3/hu unknown
- 2000-09-20 CN CN00813196A patent/CN1376070A/zh active Pending
- 2000-09-20 CA CA002383510A patent/CA2383510A1/en not_active Abandoned
- 2000-09-20 JP JP2001524618A patent/JP2003509467A/ja not_active Withdrawn
- 2000-09-20 WO PCT/EP2000/009212 patent/WO2001021194A2/en not_active Ceased
- 2000-09-20 UA UA2002043346A patent/UA73956C2/uk unknown
- 2000-09-20 SK SK375-2002A patent/SK3752002A3/sk not_active Application Discontinuation
- 2000-09-20 KR KR1020027003740A patent/KR100772852B1/ko not_active Expired - Fee Related
- 2000-09-20 CN CNA2007100789192A patent/CN101045155A/zh active Pending
- 2000-09-20 AU AU77792/00A patent/AU769482B2/en not_active Ceased
- 2000-09-20 BR BR0014198-4A patent/BR0014198A/pt not_active Application Discontinuation
- 2000-09-20 IL IL14818500A patent/IL148185A0/xx not_active IP Right Cessation
- 2000-09-20 EP EP00967722A patent/EP1214086A2/en not_active Withdrawn
- 2000-09-22 TW TW089119671A patent/TWI267373B/zh not_active IP Right Cessation
-
2002
- 2002-02-19 ZA ZA200201374A patent/ZA200201374B/en unknown
- 2002-03-21 NO NO20021430A patent/NO331198B1/no not_active IP Right Cessation
- 2002-04-05 BG BG106584A patent/BG66128B1/bg unknown
-
2011
- 2011-10-17 JP JP2011227603A patent/JP2012051920A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN101045155A (zh) | 2007-10-03 |
| JP2012051920A (ja) | 2012-03-15 |
| MXPA02002436A (es) | 2003-02-12 |
| EP1214086A2 (en) | 2002-06-19 |
| JP2003509467A (ja) | 2003-03-11 |
| WO2001021194A3 (en) | 2002-03-14 |
| NZ534836A (en) | 2007-07-27 |
| KR100772852B1 (ko) | 2007-11-02 |
| HK1049117A1 (zh) | 2003-05-02 |
| BG66128B1 (bg) | 2011-06-30 |
| BG106584A (bg) | 2003-02-28 |
| PL353244A1 (en) | 2003-11-03 |
| AU7779200A (en) | 2001-04-24 |
| NO20021430D0 (no) | 2002-03-21 |
| TR200200738T2 (tr) | 2002-08-21 |
| AU769482B2 (en) | 2004-01-29 |
| BR0014198A (pt) | 2002-05-21 |
| IL148185A0 (en) | 2002-09-12 |
| TWI267373B (en) | 2006-12-01 |
| ZA200201374B (en) | 2002-10-30 |
| HUP0202741A2 (hu) | 2003-01-28 |
| WO2001021194A2 (en) | 2001-03-29 |
| CA2383510A1 (en) | 2001-03-29 |
| NO20021430L (no) | 2002-05-07 |
| UA73956C2 (en) | 2005-10-17 |
| RU2255759C2 (ru) | 2005-07-10 |
| SK3752002A3 (en) | 2003-06-03 |
| NO331198B1 (no) | 2011-10-31 |
| PL201898B1 (pl) | 2009-05-29 |
| CN1376070A (zh) | 2002-10-23 |
| KR20020035879A (ko) | 2002-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0200992A3 (en) | Indoline derivatives as progesterone antagonists and pharmaceutical compositions containing them and their use | |
| IL147217A0 (en) | New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain | |
| HUP0203142A3 (en) | Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use | |
| HUP0302093A3 (en) | Use of conjugated estrogens and medroxyprogesterone acetate for producing pharmaceutical compositions for hormone replacement therapy | |
| HUP0104718A3 (en) | Micronized eplerenone compositions, process for their preparation and use thereof for the preparation of pharmaceutical compositions | |
| PL396568A1 (pl) | Krystaliczny bursztynian O-demetylo-wenlafaksyny, kompozycja farmaceutyczna, farmaceutyczna postać dawkowania, doustna postać dawkowania, zastosowanie oraz sposób wytwarzania krystalicznego bursztynianu O-demetylo-wenlafaksyny | |
| PL352282A1 (en) | Derivatives of thiazoles and pharmaceutical compositions containing these derivatives | |
| HUP0203588A3 (en) | Analgesic pharmaceutical compositions and their use | |
| PL355844A1 (en) | Novel pharmaceutical compositions of anti-tubrcular drugs and process for their preparation | |
| HUP0301325A3 (en) | Stabilized pharmaceutically effective composition and pharmaceutical composition comprising the same and process for preparation the composition | |
| HUP0204226A3 (en) | Quinazoline derivatives, pharmaceutical compositions containing them, their use and process for the preparation of the compounds | |
| CY2009015I2 (el) | Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο | |
| HUP0101693A3 (en) | Use of steroidal sapogenins and their derivatives for producing pharmaceutical compositions for the treatment of alzheimeirs disease | |
| HUP0004120A3 (en) | Use of cgmp-pde5 inhibitors for the preparation of pharmaceutical compositions treating neuropathy | |
| HUP0201872A3 (en) | Steroid compounds and pharmaceutical compositions of the same | |
| HUP0203311A3 (en) | New pharmaceutical compositions of prolonged effect | |
| HUP0203597A3 (en) | Pharmaceutical compositions containing zolmitriptan, process for their preparation and their use | |
| HUP0202741A3 (en) | Pharmaceutical composition available for the therapeutic management of endometriosis and fallopian tube obstruction and process for its preparation | |
| IL161348A (en) | Substituted 4- phenyl-4-[1h - imidazol-2-yl] piperidine derivatives and their use for the preparation of pharmaceutical compositions | |
| HUP0303731A3 (en) | Sulfonylguanidines and their use for preparation of pharmaceutical compositions | |
| HUP0301317A3 (en) | Use of neuroprotective 7-beta-hydroxysteroids for preparation of pharmaceutical compositions | |
| HUP0300402A3 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them | |
| HUP0201405A3 (en) | Pharmaceutical composition for therapeutic use of melatonin | |
| IL137275A0 (en) | Pharmaceutical composition for the treatment of anal fissures | |
| EE200900049A (et) | Etinlstradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC9A | Change of name, address |
Owner name: ZENTARIS GMBH, DE Free format text: FORMER OWNER(S): ZENTARIS AG., DE; ZENTARIS GMBH, DE |
|
| FD9A | Lapse of provisional protection due to non-payment of fees |